Allogeneic HCT feasible in older patients with myelodysplastic syndrome
Allogeneic hematopoietic cell transplantation (allo-HCT) is feasible in older patients with myelodysplastic syndrome (MDS), according to a study published online June 26 in the European Journal of Haematology.
5 hours ago
0
0